Skip to main content

Table 1 Clinical data of patients in the TCGA and the ICGC validation cohort

From: Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma

Variables

Subgroups

TCGA (NĀ =ā€‰370)

ICGC(NĀ =ā€‰231)

Age

<ā€‰60

169

44

>ā€‰=ā€‰60

201

187

Sex

Male

249

179

Female

121

62

Stage

I

171

36

II

85

104

III

85

72

IV

5

19

NA

24

0

Grade

I

55

ā€“

II

177

ā€“

III

121

ā€“

IV

12

ā€“

NA

5

ā€“

Survival status

Dead

130

42

Living

240

189

Vascular invasion

Positive

108

ā€“

Negative

206

ā€“

NA

56

ā€“

Family history

Positive

112

73

Negative

207

143

NA

51

15

Prior malignancy

Positive

ā€“

29

Negative

ā€“

202

NA

ā€“

0